Production & Manufacturing
News
FTC Aims Manufacturer, PBM Rebates For Rising Insulin Costs
Bribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US regulators, with a particular focus on rising insulin prices. The Federal Trade Commission (FTC) announced recently that it would step up enforcement against practises...
News
Pfizer Commits $120mn In COVID-19 U.S. Oral Drug Production
COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take, for example, Pfizer's new $120 million investment. The company announced on June 6Â that it will use the funds to expand manufacturing of its oral...
IT & Data Management
RCPE and InSilicoTrials to Digitalize and Accelerate the Development of Pharmaceutical Manufacturing Processes
RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialize the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows companies to assess their process configurations in unprecedented detail and explore the decision space without time- and...
Press Releases
PIPAc Collaboration Enables New Compact, Mobile and Frugal Approach to Active Pharmaceutical Ingredient (API) Manufacturing
The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API) production. The partnership will leverage its complementary skills to provide a complete, standalone, and...
News
Catalent Invests $175 Million In A New Factory Expansion
Catalent, a manufacturing behemoth, has announced another expansion, this time at a large oral medication plant that had previously doubled in size in 2015. Catalent is expanding its Winchester, Kentucky, plant by 107,000 square feet, creating 277 new jobs in...
Press Releases
PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England
PCI Pharma Services is pleased to announce a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important manufacturing process commonly used with injectable and biologic therapies, with the investment of $100 million...
Press Releases
Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech Firms
Lonza and ALSA Ventures Colloboration: ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced today a framework collaboration agreement to help ALSA’s portfolio...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
